Literature DB >> 10025478

Longitudinal evaluation of serovar-specific immunity to Neisseria gonorrhoeae.

K K Fox1, J C Thomas, D H Weiner, R H Davis, P F Sparling, M S Cohen.   

Abstract

The serovars of Neisseria gonorrhoeae that are predominant in a community change over time, a phenomenon that may be due to the development of immunity to repeat infection with the same serovar. This study evaluated the epidemiologic evidence for serovar-specific immunity to N. gonorrhoeae. During a 17-month period in 1992-1994, all clients of a sexually transmitted disease clinic in rural North Carolina underwent genital culture for N. gonorrhoeae. Gonococcal isolates were serotyped according to standard methods. Odds ratios for repeat infection with the same serovar versus any different serovar were calculated on the basis of the distribution of serovars in the community at the time of reinfection. Of 2,838 patients, 608 (21.4%; 427 males and 181 females) were found to be infected with N. gonorrhoeae at the initial visit. Ninety patients (14.8% of the 608) had a total of 112 repeat gonococcal infections. Repeat infection with the same serovar occurred slightly more often than would be expected based on the serovars prevalent in the community at the time of reinfection, though the result was marginally nonsignificant (odds ratio = 1.5, 95% confidence interval 1.0-2.4; p = 0.05). Choosing partners within a sexual network may increase the likelihood of repeat exposure to the same serovar of N. gonorrhoeae. Gonococcal infection did not induce evident immunity to reinfection with the same serovar.

Entities:  

Mesh:

Year:  1999        PMID: 10025478     DOI: 10.1093/oxfordjournals.aje.a009820

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  33 in total

1.  Immunogenicity of gonococcal transferrin binding proteins during natural infections.

Authors:  Gregory A Price; Marcia M Hobbs; Cynthia Nau Cornelissen
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

2.  Phosphoryl moieties of lipid A from Neisseria meningitidis and N. gonorrhoeae lipooligosaccharides play an important role in activation of both MyD88- and TRIF-dependent TLR4-MD-2 signaling pathways.

Authors:  Mingfeng Liu; Constance M John; Gary A Jarvis
Journal:  J Immunol       Date:  2010-10-29       Impact factor: 5.422

3.  Phenotypic and genotypic analyses of Neisseria gonorrhoeae isolates that express frequently recovered PorB PIA variable region types suggest that certain P1a porin sequences confer a selective advantage for urogenital tract infection.

Authors:  Lotisha E Garvin; Margaret C Bash; Christine Keys; Douglas M Warner; Sanjay Ram; William M Shafer; Ann E Jerse
Journal:  Infect Immun       Date:  2008-06-09       Impact factor: 3.441

4.  Vaccines against gonorrhea: current status and future challenges.

Authors:  Ann E Jerse; Margaret C Bash; Michael W Russell
Journal:  Vaccine       Date:  2013-09-06       Impact factor: 3.641

5.  High-level chromosomally mediated tetracycline resistance in Neisseria gonorrhoeae results from a point mutation in the rpsJ gene encoding ribosomal protein S10 in combination with the mtrR and penB resistance determinants.

Authors:  Mei Hu; Sobhan Nandi; Christopher Davies; Robert A Nicholas
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

Review 6.  Male infertility: a public health issue caused by sexually transmitted pathogens.

Authors:  Fabrícia Gimenes; Raquel P Souza; Jaqueline C Bento; Jorge J V Teixeira; Silvya S Maria-Engler; Marcelo G Bonini; Marcia E L Consolaro
Journal:  Nat Rev Urol       Date:  2014-10-21       Impact factor: 14.432

7.  Local and humoral immune responses against primary and repeat Neisseria gonorrhoeae genital tract infections of 17beta-estradiol-treated mice.

Authors:  Wenxia Song; Sara Condron; Brian T Mocca; Sandra J Veit; Dawn Hill; Asima Abbas; Ann E Jerse
Journal:  Vaccine       Date:  2008-08-30       Impact factor: 3.641

8.  Gonorrhoea reinfection in heterosexual STD clinic attendees: longitudinal analysis of risks for first reinfection.

Authors:  S D Mehta; E J Erbelding; J M Zenilman; A M Rompalo
Journal:  Sex Transm Infect       Date:  2003-04       Impact factor: 3.519

9.  Type I Interferon Induction by Neisseria gonorrhoeae: Dual Requirement of Cyclic GMP-AMP Synthase and Toll-like Receptor 4.

Authors:  Warrison A Andrade; Sarika Agarwal; Shunyan Mo; Scott A Shaffer; Joseph P Dillard; Tobias Schmidt; Veit Hornung; Katherine A Fitzgerald; Evelyn A Kurt-Jones; Douglas T Golenbock
Journal:  Cell Rep       Date:  2016-06-02       Impact factor: 9.423

10.  Functional characterization of antibodies against Neisseria gonorrhoeae opacity protein loops.

Authors:  Jessica G Cole; Ann E Jerse
Journal:  PLoS One       Date:  2009-12-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.